Please use a PC Browser to access Register-Tadawul
Get It
Novo Nordisk Confirms That It Submitted An Unsolicited Proposal To Acquire Metsera For $56.50, Equal To An Approximate Equity Value Of $6.5B Or Enterprise Value Of $6B And Contingent Value Rights For Up To $21.25
Metsera, Inc. 0.00%
Novo Nordisk A/S Sponsored ADR Class B -0.27%
Metsera, Inc. MTSR | 70.50 | 0.00% |
Novo Nordisk A/S Sponsored ADR Class B NVO | 47.86 | -0.27% |
Novo Nordisk Confirms That It Submitted An Unsolicited Proposal To Acquire Metsera For $56.50, Equal To An Approximate Equity Value Of $6.5B Or Enterprise Value Of $6B And Contingent Value Rights For Up To $21.25
